Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05628207 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of the SCALED (SCaling AcceptabLE cDs)

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 7 months later across 2 updates Jul 31, 2026 → Mar 1, 2027
See other at-risk trials from University of Minnesota

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Enrollment closed, study ongoing Show 4 more changesShow less
    • Primary and study completion pushed from Sep 30, 2026 to Mar 1, 2027
    • Site details revised
    • Publications: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 3 words
  2. Minor Primary and study completion pushed from Jul 31, 2026 to Sep 30, 2026v9
  3. Minor Primary and study completion dates: Jun 30, 2026 to Jul 31, 2026v8
  4. Notable Primary and study completion dates: Nov 16, 2025 to Jun 30, 2026v7
  5. Minor 2 versions Re-verified since Apr 23, 2024, no change to tracked fieldsv5-v6
Show 3 earlier versionsHide 3 earlier versions
  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v4
  2. Notable Start date: Apr 1, 2023 to May 16, 2023
    • Primary and study completion dates: Oct 1, 2025 to Nov 16, 2025
    v3
  3. Notable Start date: Jan 1, 2023 to Apr 1, 2023v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This project will adapt a currently deployed Clinical Decision Support (CDS) system to deliver a VTE prevention guideline for adult patients with traumatic brain injury (TBI). We believe this is an ideal PCOR use case given PCORI's continued effort to combat VTE in trauma and our experience previously implementing this guideline. The Our overall goal is to successfully scale, evaluate, and maintain an interoperable TBI CDS across 7 total institutions.
Trial Details
NCT Number NCT05628207
Lead Sponsor University of Minnesota
Collaborators: Agency for Healthcare Research and Quality (AHRQ)
Conditions
(from sponsor)
Traumatic Brain Injury, Venous Thromboembolism
Related terms Brain Injuries, Traumatic, Venous Thromboembolism
Enrollment 15,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov